Peptinovo Biopharma Inc.

Biotechnology

Peptinovo offers a targeted drug-delivery platform Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), a serious side effect.  PALM delivers higher doses of existing, proven drugs into tumors, keeping them away from healthy tissues. Lives are extended and side effects avoided.

Cantilever has invested in a SAFE agreement with this company.

www.peptinovo.com